VELEZ ENTERPRISES LLC v. KVK-TECH, INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedJune 27, 2024
Docket2:20-cv-05553
StatusUnknown

This text of VELEZ ENTERPRISES LLC v. KVK-TECH, INC. (VELEZ ENTERPRISES LLC v. KVK-TECH, INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VELEZ ENTERPRISES LLC v. KVK-TECH, INC., (E.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

VELEZ ENTERPRISES LLC d/b/a CIVIL ACTION OQSIE NO. 20-5553 v.

KVK-TECH, INC., MURTY VEPURI, and ANTHONY TABASSO

MEMORANDUM RE: PARTIAL MOTIONS FOR SUMMARY JUDGMENT Baylson, J. June 27, 2024 This case involves Plaintiff Velez Enterprises LLC’s breach of contract and unjust enrichment claims against Defendants KVK-Tech, Inc. (“KVK”), Murty Vepuri, and Anthony Tabasso. Plaintiff alleges that Defendants failed to pay roughly $1.9 million in consulting fees associated with Defendants’ efforts to remediate several compliance violations raised by the Food and Drug Administration (“FDA”). Presently before this Court are the Parties’ cross-motions for partial summary judgment. For the reasons explained below, Plaintiff’s motion is DENIED, and Defendants’ motion is GRANTED IN PART, DENIED IN PART. I. FACTUAL BACKGROUND A. FDA Warning Letter and OQSIE Engagement

On February 11, 2020, the FDA issued a warning letter to Defendant KVK, a generic pharmaceuticals manufacturer. ECF 161-1 at ¶¶ 1, 22. The Warning Letter alleged KVK’s noncompliance with the Food, Drug, and Cosmetic Act and FDA regulations, and demanded that KVK remediate the alleged violations or face imminent “legal action without further notice.” Id. at ¶¶ 24-25. The FDA also “strongly recommend[ed] that [KVK] retain a qualified consultant to assist in [its] remediation,” and required KVK to “respond to [the FDA] in writing within 15 working days” to “[s]pecify what [KVK had] done since [the FDA’s] inspection to correct [the alleged] violations and to prevent their recurrence.” Id. at ¶¶ 26-27. KVK’s outside counsel recommended Plaintiff—Velez Enterprises (d/b/a OQSIE)—as a possible consultant. Id. at ¶ 29. Following that recommendation, Defendant Tabasso, President

and In-House Counsel for KVK, reached out to OQSIE member Jaime Velez. Id. at ¶ 30. The following day, OQSIE’s other member at the time, William Schmidt, visited KVK to discuss the potential engagement. Id. at ¶ 33. At that time, “the support that [KVK] requested initially revolved around . . . having to respond to the FDA in three weeks.” Id. at ¶ 31. B. OQSIE’s February 15, 2020 Proposal

On February 15, 2020, OQSIE provided a proposal to KVK. Id. at ¶ 36. Per that proposal, OQSIE planned to investigate and respond to the Warning Letter in phases: (1) the initial response, (2) the assessments necessary to develop remediation proposals, and (3) remediation. Id. at ¶ 35. Importantly, it is undisputed that the February 15 proposal was not for actual remediation work. Id. at ¶ 37; ECF 168-3 at ¶ 37. Rather, the February 15 proposal addressed two phases of work lasting approximately six weeks, with a budget of $240,000. ECF 161-1 at ¶ 38; ECF 168- 3 at ¶ 38. The first three-week phase involved developing KVK’s initial Warning Letter response. The next three-week phase was “about organizing the remediation activities.” ECF 161-1 at ¶ 39; ECF 168-3 at ¶ 39. KVK accepted the proposal on February 17, 2020, and work commenced. ECF 161-1 at ¶ 59. Notably, neither Party disputes that KVK has paid all fees associated with the February 15 proposal. ECF 161-1 at ¶ 49; ECF 168-3 at ¶ 49.

C. OQSIE’s March Proposals On March 3, 2020, OQSIE sent a “proposal support for remediation planning and execution.” ECF 161-1 at ¶ 50; ECF 168-3 at ¶ 50. This proposal was for “a continuation of the planning and the execution activities associated with the [Warning Letter] response.” Id. The work connected to this proposal was to “inform what work needed to be done to meet

the . . . initial commitments that were made to the FDA,” and had a budget of $721,500. ECF 161- 1 at ¶¶ 53, 55; ECF 168-3 at ¶¶ 53, 55. For this proposal, Defendants assert that Velez testified the work ran through August 21, 2020. ECF 161-1 at ¶ 54; but see ECF 168-3 at ¶ 54 (instead alleging that “Velez testified [] as to the estimate of when funds would be consumed by the team of consultants proposed at that time, and not for work that would be completed by that date”). Although this proposal accounted for consultants who were already working on the KVK project, it allegedly did not account for additional consultants who were added later. Id. Importantly, Schmidt testified that KVK “needed to approve” this proposal. ECF 161-1 at ¶ 56; ECF 168-3 at ¶ 56. Yet, no one from KVK ever signed this March 3 proposal. ECF 161-1 at ¶ 57; ECF 168-3

at ¶ 57. To the contrary, on March 5, 2020, Tabasso wrote to Schmidt that “[w]e are in contact with a former FDA guy as a data integrity consultant. I want to interview him and then circle back.” ECF 170-1 at ¶ 55. That said, on March 9, 2020, OQSIE presented KVK with a “launch plan for post Warning Letter response activities.” ECF 161-1 at ¶ 58. Defendants allege this launch plan was slated to take place over “the next four weeks or so.” ECF 161-1 at ¶ 58. Plaintiff instead asserts that “the plain language of that document is clear in that it established a 12 months’ timeline for Observation 2 activities and an estimate of between 20 and 38 consultants to support this activity.” ECF 168- 3 at ¶ 58. Defendants also contend this proposal related to the “assessments and development of the remediation plan.” ECF 161-1 at ¶ 59; but see ECF 168-3 at ¶ 59 (same objection). More precisely, Defendants note that Velez himself testified that the March 9 plan was “the execution of the plan of the commitments that were made in the Warning Letter.” ECF 161-1 at ¶ 60; but see ECF 168-

3 at ¶ 60 (same objection). In presenting the March 9 plan, Defendants assert that OQSIE indicated that it anticipated adding nine consultants to the team currently working with KVK. ECF 161-1 at ¶ 61; but see ECF 168-3 at ¶ 61 (denying that “KVK was not aware of the need for additional consultants at this time for the KVK Project because OQSIE’s March 9, 2020 Proposal clearly and unambiguously established a 12 months’ timeline for Observation 2 activities and an estimate of between 20 and 38 consultants to support this activity.”) While Defendants assert that no one from KVK ever signed off on this plan, in an email that same day, Tabasso responded that “the biggest challenge for us at this point is going to be seating,” but that “[l]aptops will be here for everyone next Monday.” ECF 163-10 at 2.

D. OQSIE April Request for More Consultants

In an April 17, 2020 email, OQSIE requested to deploy additional consultants. ECF 159- 3 at ¶ 19, ECF 163-11. It is not clear from the record whether a KVK representative ever responded to this email. That said, the record also reflects that OQSIE consultants continued their work for KVK and that KVK was aware OQSIE had deployed an additional twenty-nine consultants around this time. ECF 159-3 at ¶ 21.

E. OQSIE May Request for Master Services Agreement In May 2020, OQSIE requested that KVK enter into a Master Services Agreement. ECF 161-3 at ¶¶ 69-70; ECF 159-3 at ¶¶ 30-31. Specifically, on May 14, 2020, Velez emailed Kiran Vepuri, a KVK representative, stating that “[t]he response letter and associated protocols reference a services agreement document in place between KVK and OQSIE,” and that Velez believed the

Parties should execute one. Id. Despite this request, however, KVK and OQSIE never entered into an MSA or any other overarching contract. ECF 161-3 at ¶ 71; ECF 159-3 at ¶ 30. F. KVK Complaints

Around this same time, KVK began to express dissatisfaction with OQSIE’s work, raising concerns about consultant efficiency and productivity. ECF 163-16. KVK also disputed several of OQSIE’s bills. Id.; ECF 163-17. According to Defendants, OQSIE allegedly never addressed those concerns. ECF 161 at 7. G. June 2020 Remediation Plan and July 2020 Termination

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Mellon Bank, N.A. v. Aetna Business Credit, Inc.
619 F.2d 1001 (Third Circuit, 1980)
Hullett v. Towers, Perrin, Forster & Crosby, Inc.
38 F.3d 107 (Third Circuit, 1994)
Ferrer v. Trustees of the University of Pennsylvania
825 A.2d 591 (Supreme Court of Pennsylvania, 2002)
Hutchison v. Sunbeam Coal Corp.
519 A.2d 385 (Supreme Court of Pennsylvania, 1986)
AM/PM Franchise Ass'n v. Atlantic Richfield Co.
584 A.2d 915 (Supreme Court of Pennsylvania, 1990)
Delahanty v. First Pennsylvania Bank, N.A.
464 A.2d 1243 (Supreme Court of Pennsylvania, 1984)
Torchia on Behalf of Torchia v. Torchia
499 A.2d 581 (Supreme Court of Pennsylvania, 1985)
Johnston the Florist, Inc. v. TEDCO Construction Corp.
657 A.2d 511 (Superior Court of Pennsylvania, 1995)
Securities & Exchange Commission v. Thrasher
152 F. Supp. 2d 291 (S.D. New York, 2001)
Martin v. City of Reading
118 F. Supp. 3d 751 (E.D. Pennsylvania, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
VELEZ ENTERPRISES LLC v. KVK-TECH, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/velez-enterprises-llc-v-kvk-tech-inc-paed-2024.